WESLEY HARDIN: Open Payments
NPI 1598057630 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 76 payments from 25 companies in 2025. Trend: 2023 $1,343 · 2024 $1,537 · 2025 $1,509
Food & beverage: $1,509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $211 |
| Madrigal Pharmaceuticals | 4 | $138 |
| PFIZER INC. | 6 | $127 |
| Novo Nordisk Inc | 6 | $119 |
| Exact Sciences Corporation | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Ardelyx, Inc. | 4 | $69 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Lilly USA, LLC | 3 | $58 |
| QOL Medical, LLC | 2 | $57 |
Products named: REZDIFFRA, LINZESS, IBSRELA, CREON, Wegovy, GATTEX, OMVOH, Sucraid.
Industry payments across FL — which companies pay providers there.
